Fin Maverick
Foundations VocabularyAccounting & ReportingEconomics & MacroQuant Methods & ProgrammingBusiness & Company AnalysisCorporate Finance & ValuationBehavioural Finance
Banking & Market InfrastructureFixed Income & RatesDerivatives & Structured ProductsPublic EquitiesTransactions & DealsPortfolio ConstructionFunds & AMCs
Private Markets & AlternativesRisk, Treasury & ControlAI & Digital FinanceStochastic Calculus & PricingWealth & Personal FinanceIndian Markets & RegulationProfessional Practice
CalculatorComparison
Frameworks
Explore Bootcamps
Equity ResearchPortfolio ManagementMutual Fund MasteryInvestment Banking Analyst
Private Equity AnalystQuant & Hedge Fund AnalystBreaking Into VCFinancial Analyst Program
Risk Management ProgramPrivate Wealth ManagementDebt Capital MarketsDerivatives Foundation
Explore Free Courses

Equity Research6

Writing an Investment ThesisBuilding a Discounted Cash FlowReading an Annual Report FastReading a Sector Before a CompanySpotting Quality of Earnings Red FlagsBuilding a Revenue Forecast From Drivers

Portfolio Management3

Rebalancing: When, Why and What It CostsStrategic and Tactical Asset AllocationMeasuring Risk in a Portfolio

Mutual Fund Mastery3

Comparing Funds Without Being FooledHow a NAV Is Struck and Which Day You GetReading a Fund Factsheet Properly

Derivatives Unlocked4

Hedging a Real ExposureThe Greeks, PracticallyFutures, the Basis and What Moves ItReading an Option Payoff

AI For Finance2

Retrieval and Grounding for FinanceDocument Extraction in Finance

Breaking Into Quants4

Backtesting a StrategyHypothesis TestingCleaning Financial DataRegression for Finance

Breaking Into VC3

Sizing a MarketReading a Term Sheet as a FounderHow a Venture Round Actually Works

Financial Analyst Program4

Common Size and Trend AnalysisReading a Cash Flow StatementRatio Analysis That Says SomethingBuilding a Working Capital Schedule

Risk Management Program2

Credit Exposure and How It Is ReducedValue at Risk and What It Hides

Investment Banking Analyst3

Precedent Transactions and Why They DifferReading a Term Sheet StructurallyBuilding a Comparable Companies Table

Private Wealth Management3

Tax Aware Portfolio DecisionsBuilding a Client Risk ProfileGoal Based Planning Arithmetic

Debt Capital Markets3

Analysing an Issuer's CreditDuration and What It Does Not Tell YouBond Pricing and Yield Mechanics

Private Equity Analyst2

Fund Waterfalls and CarryThe LBO in Structure

Hedge Funds Analyst2

Short Selling MechanicsLong Short Mechanics
QuarksCourses
Explore Interview Preparation
Investment BankingEquity ResearchVenture CapitalistPrivate EquityHedge Funds
QuantFinancial AnalysisPrivate Wealth ManagementDebt Capital MarketsRisk Management
Derivatives FoundationPortfolio ManagementMutual Fund Mastery
PartnershipsShowdown
Log inSign up
Interview tracksAll
1Investment Banking
Question bankPuzzlesCase studies
2Equity Research
Question bankPuzzlesCase studies
3Venture Capital
Question bankPuzzlesCase studies
4Private Equity
Question bankPuzzlesCase studies
5Hedge Funds
Question bankPuzzlesCase studies
6Quant
Question bankPuzzlesCase studies
7Financial Analysis
Question bankPuzzlesCase studies
8Private Wealth Management
Question bankPuzzlesCase studies
9Debt Capital Markets
Question bankPuzzlesCase studies
10Risk Management
Question bankPuzzlesCase studies
11Derivatives Foundation
Question bankPuzzlesCase studies
12Portfolio Management
Question bankPuzzlesCase studies
13Mutual Fund Mastery
Question bankPuzzlesCase studies
052

Case 052Distress and restructuringCore

Kamalnayan Hotels is at 4.6x net debt to EBITDA against a 4.0x covenant. Size an equity cure, a hotel sale and a waiver, and say which you would use.

1The situation

Kamalnayan Hotels runs a chain of business hotels. Trailing EBITDA is Rs 250 crore and net debt is Rs 1,150 crore, so leverage is 4.6x. Its bank loan carries a maintenance covenant: net debt to EBITDA no higher than 4.0x, tested every quarter. The next test is in ten weeks.

The board has three options on the table. Promoters can inject equity to cure the breach. The company can sell one hotel that earns Rs 30 crore of EBITDA; a buyer has indicated 12x. Or the lenders will waive the breach for a fee of 0.5% of the debt.

2Your task

How large does each fix need to be, what does each one cost, and which would you recommend?

Quick check

Which fix lowers leverage the most?

Worked solution

Try it on paper, then open one step at a time.

30-second answerThe answer to give first

A cure needs Rs 150 crore of equity, the hotel sale takes leverage to about 3.6x, and a waiver costs Rs 5.75 crore but fixes nothing. The cure lands exactly on 4.0x with no headroom. The sale cuts Rs 360 crore of debt for Rs 30 crore of EBITDA, leaving room for EBITDA to fall about 10%. Take the waiver as a bridge, sell the hotel to fix the ratio, and keep the cure as the fallback.

Step 1What exactly is broken?

A ratio, and a ratio has three ways to move. Leverage is net debt over EBITDA, so you can shrink the top, grow the bottom, or ask the person who set the limit to look away. A household whose EMIs have grown past the share of salary a bank allows has the same three choices: prepay with savings, earn more, or ask the bank for a holiday. Write the ratio first: Rs 1,150 crore over Rs 250 crore is 4.6x, and 4.0x times Rs 250 crore means debt must come down to Rs 1,000 crore.

Step 2How big does each fix have to be?

The equity cure is the gap between actual and permitted debt: Rs 1,150 crore less Rs 1,000 crore, so Rs 150 crore. Some loan agreements instead let the cure count as deemed EBITDA, which is far cheaper: EBITDA would need to reach 1,150 over 4.0, Rs 287.5 crore, so a cure of only Rs 37.5 crore. Ask which version the equity cureA clause letting shareholders put in fresh money to fix a failed financial covenant, counted either as debt repaid or as extra EBITDA. clause uses before sizing anything. The hotel sale raises 12 times Rs 30 crore, Rs 360 crore. Net debt falls to Rs 790 crore, EBITDA to Rs 220 crore, and leverage to 3.59x. The waiver costs 0.5% of Rs 1,150 crore, Rs 5.75 crore, and leaves the ratio at 4.6x.

Three fixes: move the debt, move the EBITDA, or move the lenderToday, in breachnet debt 1,150 / EBITDA 2504.6xEquity cure, Rs 150 croredebt 1,000 / 250, zero headroom4.0xSell hotel at 12xdebt 790 / 220, EBITDA can fall 10%3.59xWaiver, fee Rs 5.75 crorebreach excused, not fixed4.6xcovenant 4.0x
Against a 4.0x covenant, a Rs 150 crore equity cure takes Kamalnayan from 4.6x to exactly 4.0x, selling a hotel at 12x takes it to 3.59x, and a waiver leaves it at 4.6x with the breach excused rather than fixed.
FixWhat movesCash cost, Rs croreLeverage afterEBITDA headroom
Equity cureDebt down 150150 of new equity4.00x0%
Hotel sale at 12xDebt down 360, EBITDA down 30None; gives up 30 of EBITDA3.59x10.2%
WaiverNothing5.75 fee4.60xNegative
Only the hotel sale leaves headroom: at Rs 790 crore of net debt, EBITDA can fall from Rs 220 crore to Rs 197.5 crore, about 10%, before the 4.0x covenant bites again.
Step 3Why is the cheapest-looking fix not the answer on its own?

Because a covenant is tested every quarter and the business that breached it has not changed. A cure that lands exactly on 4.0x leaves no room for a bad month, so the next test can fail again. To match the sale's headroom, the cure would need to take leverage to 3.59x, which means about Rs 252 crore of equity. The waiver is cheap in cash, but lenders usually pair it with a higher margin and tighter terms, and it only moves the problem forward a quarter.

Step 4So what do you recommend, and in what order?

Sequence them. A hotel sale will not close in ten weeks, so take the waiver now as a bridge, use the time to sell the hotel at 12x, and keep the equity cure as the fallback if the sale slips. The sale is the only option that improves the balance sheet rather than paper over it, and it is value-friendly if the group trades below 12x EBITDA: shareholders swap Rs 30 crore of EBITDA for more debt reduction than the market would credit it with. The cost is a smaller business and Rs 30 crore less EBITDA to grow from, which is worth saying.

State the limit. Taxes on the sale gain, transaction costs and any hotel-level debt that must be repaid first would all reduce the Rs 360 crore, and the lender may insist that sale proceeds repay its loan rather than sit as cash. Check all three before promising the board a number.

Where candidates lose it

The common miss is sizing the cure correctly and stopping. Rs 150 crore lands exactly on the limit; the interviewer wants to hear that a fix with zero headroom is not a fix, and that the sale multiple matters because it beats the group's leverage.

The second is forgetting that the asset sale also removes EBITDA. Dividing Rs 790 crore by the old Rs 250 crore gives 3.2x and overstates the improvement.

What the interviewer asks next

  • The buyer cuts its offer to 8x. Does the hotel sale still help the ratio?
  • How would the answer change if the cure counted as deemed EBITDA?
  • What would lenders ask for in return for the waiver beyond the fee?
← Case 051Paper LBO over the phone: Neerbahini Pumps has EBITDA of Rs 100 crore growing 7% a year, bought at 8x with 5x debt at 10%, and all cash after interest repays debt. What are the money multiple and the IRR?Case 053 →Krishivan AgriTech raises Rs 300 crore at a Rs 3,000 crore pre-money valuation, with revenue growing from Rs 250 crore and an exit at 4x revenue in year 5. What return does the investor make, and what must go right?

Company names and figures are illustrative.

Fin Maverick Free CoursesExplore Free Courses
Fin Maverick BootcampsExplore Bootcamps
Fin Maverick

Finance education that ends in a job, not a certificate that gathers dust. Built for young India.

LEARN
CalculatorsFrameworksComparisonsInterview RoadmapsShowdown
RESOURCES
All CoursesFree CoursesBootcampsInternships
COMPANY
AboutJob openingPartnership
LEGAL
Privacy PolicyTerms & ConditionsContent LicenseReturn & Refund Policy
© 2026 FIN MAVERICK / BUILT FOR INDIA.DO FINANCE, DO NOT JUST READ ABOUT IT.